Dana Point, CA, United States of America

John E Donello

This inventor holds 136 USPTO granted patents and 80 published patent applications, plus 22 CIPO patents and 60 EPO patents, primarily in Pharmaceutical Compositions (CPC class C07D233-64). Top assignees: Allergan, Inc., Exonhit Therapeutics, Sa, Allergan Sales, Inc.. Active years: 2001-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John E Donello. Retrieved from https://idiyas.com/inventor/john-e-donello

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 136 (Patent Applications = 80)

% Patents Active = 76.5

CIPO Patents = 22 (Patent Applications = 15)

EPO Patents = 60 (Patent Applications = 90)

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 481(Granted Patents)

Forward Citations (Not Self Cited) = 294(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Clemente, CA (US) (2016)
Dana Point, CA (US) (2001 - 2022)

Company Filing History:

Exonhit Therapeutics, Sa

where one patent can have more than one assignee

Years Active: 2001-2022

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Formyl Peptide Receptor

Retinal Diseases

Dermatological Diseases

Ocular Inflammatory Diseases

Chemokine Receptor Modulators

Adrenergic Receptor Agonists

Immuno Stimulant Activity

Cognitive Disorders

Sulfur Derivatives

Amide Derivatives

PDE 10A Inhibitors

136 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11331306 - Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases (2022-05-17),

2. 11208377 - 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof (2021-12-28),

3. 11046644 - Sulfur derivatives as chemokine receptor modulators (2021-06-29),

4. 10993931 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators (2021-05-04),

5. 10899780 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases (2021-01-26),

6. 10799518 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases (2020-10-13),

7. 10555933 - Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases (2020-02-11),

8. 10434112 - Use of agonists of formyl peptide receptor 2 for treating dermatological diseases (2019-10-08),

9. 10287243 - Sulfur derivatives as chemokine receptor modulators (2019-05-14),

10. 10251865 - Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists (2019-04-09),

11. 10208071 - Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases (2019-02-19),

12. 10201535 - Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions (2019-02-12),

13. 10172832 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators (2019-01-08),

14. 10123988 - Compositions including encapsulated isotretinoin and methods for use thereof (2018-11-13),

15. 9974772 - Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators (2018-05-22),

Title: John E Donello: Pioneering Innovator in Pharmaceutical Compositions

Introduction:

In the world of pharmaceutical research and development, certain individuals leave an indelible mark with their innovative contributions. John E Donello is one such visionary inventor who has made significant breakthroughs in the field. Based in Dana Point, CA, John E Donello has amassed an impressive number of patents and has worked with renowned companies such as Allergan, Inc. and Exonhit Therapeutics, SA. This article delves into his latest patents, career highlights, notable collaborations, and the lasting impact of his work.

Latest Patents:

One of John E Donello's recent patents encompasses his groundbreaking invention: pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases. These compositions serve as potential pharmaceuticals for the treatment of retinal diseases, retinal neuroprotection, and vision enhancement. This innovative approach demonstrates Donello's dedication to addressing medical challenges and improving patients' lives.

Additionally, he holds a patent related to the use of 3,4-disubstituted 3-cyclobutene-1,2-diones in treating inflammatory and autoimmune diseases. These compounds open avenues for developing novel therapies for patients with these conditions.

Career Highlights:

With an impressive total of 136 patents to his name, John E Donello has achieved notable recognition within the pharmaceutical industry. Throughout his career, he has displayed a keen ability to identify unmet medical needs and devise novel solutions to address them. His patents demonstrate a diverse range of innovative ideas and approaches that have the potential to vastly impact patient care in various therapeutic areas.

Collaborations:

Collaboration plays a crucial role in fostering innovation, and John E Donello has had the pleasure of working with accomplished professionals in his field. Noteworthy collaborators include Michael E Garst and Richard L Beard. Their combined expertise and collaborative efforts have undoubtedly contributed to the success of several groundbreaking inventions.

Conclusion:

John E Donello's innovative contributions and remarkable patent portfolio cement his status as a pioneering inventor in the pharmaceutical industry. His dedication to finding solutions for retinal diseases and his exploration of potential treatments for inflammatory and autoimmune conditions highlight his commitment to improving patient outcomes. With an impressive career spanning across prominent companies, John E Donello's work serves as a testament to the power of innovation and collaboration in advancing medical research and patient care.

For further information about John E Donello's patents, career, and other notable inventors and inventions, be sure to visit our website idiyas.com, where you can explore a wealth of information about the world of innovations and patents.

Profile summary based on public USPTO records.